A genetically edited form of a herpes simplex virus has outperformed a leading vaccine candidate in a new study. When challenged with a virulent strain of the sexually transmitted HSV-2, vaccinated guinea pigs displayed fewer genital lesions, less viral replication and less of the viral shedding that most readily spreads infection.
Click here for original story, Vaccine shows promise against herpes virus
Source: ScienceDaily